Internal Medicine, Hematology & Oncology · Birmingham, AL
NPI
1598979973
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
513 Brookwood Blvd Ste 275
Birmingham, AL, 35209
Phone (205) 502-4700
Groups this clinician bills Medicare through
Medicare paid, 2024
$48K
1,543 services
Medicare patients, 2024
193
Average age 75
Drug cost, 2024
$3.8M
1,819 prescriptions
Company payments, 2025
$2,180
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jonathan M Bridges was code 99214 (office e&m - established), 143 times for 45 patients. In total Jonathan M Bridges billed 1,543 services in 31 codes, and Medicare paid $48K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 143 | 45 | $66.38 | $9,492 |
| 99213 Office E&M - Established | Facility | 127 | 103 | $42.85 | $5,442 |
| 99232 Hospital E&M - Subsequent | Facility | 32 | 24 | $55.57 | $1,778 |
| 85025 Blood Count | Office | 16 | 14 | $7.61 | $122 |
| 99222 Hospital E&M - Initial | Facility | 14 | 12 | $94.71 | $1,326 |
| 99205 Office E&M - New | Facility | 11 | 11 | $116.94 | $1,286 |
By year: 2022 $613K for 40,176 services; 2023 $685K for 30,516 services; 2024 $48K for 1,543 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 16 | 14 | $7.61 | $122 |
Medicare prescription drug claims, 2024
In 2024, the drug Jonathan M Bridges prescribed most often to Medicare patients was Letrozole, with 200 prescriptions and refills. In total Jonathan M Bridges wrote 1,819 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 200 | 358 | 52 | $3,281 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 119 | 119 | 28 | $3,868 |
| Gabapentin Generic | 86 | 97 | 17 | $989 |
| Eliquis Apixaban | 86 | 94 | 16 | $56K |
| Imbruvica Ibrutinib | 78 | 78 | Under 11 | $1.2M |
| Exemestane Generic | 76 | 118 | 14 | $7,181 |
| Oxycodone Hcl Generic | 52 | 52 | 11 | $1,094 |
| Alprazolam Generic | 42 | 46 | Under 11 | $183 |
| Anastrozole Generic | 37 | 88 | Under 11 | $654 |
| Prednisone Generic | 35 | 37 | Under 11 | $130 |
| Ondansetron Hcl Generic | 34 | 40 | 18 | $739 |
| Pantoprazole Sodium Generic | 33 | 65 | Under 11 | $375 |
| Tramadol Hcl Generic | 29 | 29 | Under 11 | $126 |
| Levothyroxine Sodium Generic | 28 | 50 | Under 11 | $401 |
| Pomalyst Pomalidomide | 28 | 28 | Under 11 | $639K |
Brand drugs: 392 claims; generic drugs: 1,427 claims; opioid claims: 250.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jonathan M Bridges $2,180 ($2,180 in general payments such as food, travel and fees) from 34 companies. The largest payer was Novartis Pharmaceuticals Corporation with $315.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 17 | $315 |
| Eisai Inc. 4523.T | 10 | $157 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $146 |
| Deciphera Pharmaceuticals Inc. | 6 | $117 |
| Lilly USA, LLC LLY | 5 | $103 |
| Gilead Sciences, Inc. GILD | 4 | $101 |
| US Oncology Corporate, Inc. | 1 | $100 |
| Seagen Inc. PFE | 1 | $99.95 |
| Daiichi Sankyo Inc. 4568.T | 5 | $92.91 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $86.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.